相关实验视频
Updated: May 6, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.6K
皮肤血管肉瘤的综述:流行病学,诊断,预后和治疗选择
Kohei Yamakawa1,2, Dai Ogata1, Kenjiro Namikawa1
1Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Japanese journal of clinical oncology
|May 17, 2025
概括
皮肤血管肉瘤 (cAS) 是一种罕见的血管癌,预后不佳. 对其遗传原因的研究和针对性疗法和免疫疗法等新疗法为更好的患者结果提供了希望.
科学领域:
- 在瘤学瘤学.
- 血管生物学 血管生物学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤血管肉瘤 (cAS) 是一种罕见的,具有攻击性的恶性血管瘤,起源于内皮细胞.
- 它通常影响皮肤和软组织,由于其预后不佳和5年生存率低 (9%) 构成重大挑战.
研究的目的:
- 审查当前对皮肤血管肉瘤 (cAS) 的理解.
- 总结病变发生,临床表现,诊断和治疗策略.
- 为了突出最近的进展和未来的方向在管理这种恶性瘤.
主要方法:
- 对皮肤血管肉瘤 (cAS) 当前研究的文献综述.
- 对分子特征,遗传改变和治疗点的分析.
- 综合关于多学科管理方法的信息.
主要成果:
- 已经确定了cAS中经常发生的基因变异,为新的向疗法铺平了道路.
- 多学科管理 (手术,放射,全身疗法) 是当前的护理标准.
- 转移性cAS的结果仍然很差,强调需要改进治疗策略.
结论:
- 对分子驱动因素和免疫疗法的持续研究有望改善皮肤血管肉瘤 (cAS) 的结果.
- 对这种具有挑战性的恶性瘤来说,对向疗法和新型治疗方式的进一步研究至关重要.
相关概念视频
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Skin Cancer
5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870

